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Objective: The objective of this study was to assess the mean intima-media thickening of 
carotid arteries of elderly subjects, and its relationship with age, anthropometric measurements, 
high systolic blood pressure and dyslipidemia.
Methods: In this investigation, 129 subjects were enrolled between 1995 and 1998, age ranging 
from 29 to 94 years. They were assigned to one of 4 groups, including 2 control groups (group I, 
of healthy younger subjects; group II of healthy elderly subjects). Groups III and IV included 
those who presented with isolated systolic hypertension (ISH), and ISH and dyslipidemia, 
respectively. All subjects were submitted to a medical interview, lab tests with measurement 
of cholesterol levels, electrocardiogram, and carotid ultrasound. The ultrasound included mea-
surement of the intima-media thickening (IMT) of the carotid arteries, the right carotid artery 
(RCA) and left carotid artery (LCA), and assessment of the presence of plaques. Blood fat and 
glucose were measured by a standard method. The results were compared among the groups 
through statistical tests. The tests employed were: Chi-Square, Pearson’s and Likelihood Ratio, 
Student’s t, Mann-Whitney; ANOVA followed by Tukey’s test, Kruskal-Wallis nonparametric 
test, and test for multiple comparisons and Odds Ratio determination (OR).
Results: In this investigation, a positive association was observed between aging and IMT. In 
relation to systolic hypertension, a signiﬁ  cant association was observed with IMT (IMT-RCA 
p = 0.0034; IMT-LCA p = 0.0196; IMT-RLCA p = 0.0299), and with the presence of plaques 
(PlaqueR p = 0.0110; PlaqueL p = 0.0294; PlaqueRL p = 0.0040).
Conclusion: This investigation evidenced the important role of aging in IMT, and of systolic 
hypertension in the IMT and presence of plaque. However, further studies are needed for a 
better understanding of the actual role of risk factors in aging.
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Introduction
The aging of the population is, currently, a major phenomenon, drawing the atten-
tion of a number of investigators (Kalache et al 1987; OMS 1997). The signiﬁ  cant 
increase of life expectancies over the past few decades, in addition to social and 
economic consequences, has lead to a major change in the morbidity and mortal-
ity proﬁ  le of elders, the so-called, Epidemiologic Transition. The impact on health 
services is highly important, as individuals of 60 years or older present high preva-
lence of chronic degenerative diseases, which cause dependency and impairment 
(Lewis 1993). According to the American Heart Association Statistical Update 
(2007), from the 79 400 000 American adults with one or more cardiovascular dis-
ease (CVD), it is estimated that 37 500 000 are 65 years old or older. These ﬁ  gures 
reﬂ  ect the importance of the atherosclerotic process in the elderly, highlighting the Clinical Interventions in Aging 2008:3(3) 526
de Freitas et al
need for prevention and detection. However, studies in the 
ﬁ  eld of geriatrics, still at an early stage, are uncertain as 
to the predictive value of risk factors (RF) for CVD in the 
elderly, particularly in those older than 75 years. Based on 
this, some authors are currently studying the relationship 
between the process of atherosclerosis in the elderly and 
a number of RF (Kannel 1996; Howard et al 1997; Wil-
liams et al 2002; Davidson et al 2003). Aging, high blood 
pressure (BP), dyslipidemia, and obesity are among the RF 
that may lead to endothelial dysfunction and, therefore, to 
vascular changes.
A number of trials have indeed shown a clear association 
between dyslipidemia, and high BP and intima-media 
thickness (IMT) (Luscher et al 1991, 1992; Endemann and 
Schiffrin 1992; Fabris et al 1994; Bilato and Crow 1996; 
Cutler 1996; La Rosa 1996; O’Leary et al 1996; Howard 
et al 1997; Wilt et al 1997; Millio et al 2006; Fletcher et al 
2007). The ageing process by itself causes changes both in 
the architecture and constitution of the vascular wall. The 
aging endothelium releases less nitric oxide (NO), which is 
important for vascular relaxation. The collagen increases, 
whereas elastine becomes progressively disrupted, thinner, 
and often fragments itself. Deposits of fat and calcium are 
formed, with concurrent loss of elasticity. These aging-
related vascular changes have important medical implications 
in CVD pathogenesis (Libby 2006). The pathophysiology 
of the arterial hypertension is highly complex, with a 
number of related factors, including changes in a number of 
systems, even affecting the relation between the thickness 
of the arterial wall and its lumen. A number of noninvasive 
studies of the carotids with the use of ultrasound have shown 
the role of RF, high BP among them, in the genesis of IMT 
(Suurkula et al 1994, 1996; Bonithon-Kopp et al 1996; 
Panza 1997; Wilson et al 1997; Wang et al 2006). In the 
elderly population, it has been observed that the prevalence 
of isolated systolic hypertension (ISH) reaches about 50% 
of these individuals, and seems to be more associated to 
cardiovascular (CV) events than to systolic and diastolic 
or isolated diastolic hypertension (JNC VIII 2003; Wang 
et al 2006).
At an early stage, atherosclerosis is characterized by an 
accumulation of macrophages, involving remainders of low 
density lipoprotein cholesterol (LDL-c) and cholesterol in the 
subendothelial space of the vessel (Noll and Luscher 1994; 
Baldassare et al 1996; Jorge 1997; III Brazilian Consensus 
of Dyslipidemia 2001; Endemann and Schiffrin 2004). Even 
though a consensus seems to have been reached regarding 
the inﬂ  uence of lipoproteins on the onset of CVD, their role 
as a predictor of CV RF in the elderly is still being discussed 
(Luscher et al 1991, 1992; Fabris et al 1994; Bilato and 
Crow 1996; Cutler 1996; La Rosa 1996; O’Leary et al 1996; 
Howard et al 1997; Williams et al 2002; Endemann and 
Schiffrin 2004; Millio et al 2006; Fletcher et al 2007) On 
the other hand, evidence that hyperlipemia leads to carotid 
IMT (Bonithon-Kopp et al 1996) has triggered a number of 
studies with ultrasound assessment, which have shown a 
positive relationship between carotid IMT and LDL-c, even 
in elderly subjects.
Within this framework, the purpose of this investigation 
was: 1) to assess the intima-media complex of carotid arteries 
through ultrasound examination in healthy elderly, elderly 
with ISH, and elderly with ISH and dyslipidemia, and 2) to 
establish, among the variables age, anthropometric measure-
ments, high BP, and dyslipidemia, those that correlate the 
best with the IMT of the investigated population.
Subjects and methods
Subjects
For this investigation, 129 subjects were enrolled between 
1995 e 1998, divided in 4 groups (Table 1): 2 control groups 
or healthy individuals, 1 group of patients with ISH, and 1 
group of patients with ISH and dyslipidemia. 30 subjects were 
assigned to group I, consisting of 19 males (63.3%) and 11 
females (36.6%), according to the following inclusion crite-
ria: (1) age between 18 and 35 years, (2) normotensives, (3) 
normocholesterolemics, and (4) not using CV drugs. Group 
II included 30 subjects, consisting of 10 males (33.33%) and 
20 females (66.66%), according to the following inclusion 
criteria: (1) age of 60 or older, (2) normotensives, (3) nor-
mocholesterolemics, and (4) not using CV drugs. 30 patients 
to group III were assigned, including 12 males (40%) and 18 
females (60%); eligibility criteria included: (1) age 60 years 
or older, (2) presence of ISH, (3) normocholesterolemics, 
and (4) use of antihypertensive agents limited to angioten-
sina-converting enzyme (ACE) inhibitor and/or diuretics. 
Lastly, 39 subjects were assigned to group IV, consisting 
of 15 males (38.46%) and 24 females (61.54%), who met 
the eligibility criteria of: (1) age of 60 years or older, (2) 
presence ISH, (3) presence of hyperlipemia, and (4) use of 
antihypertensive agents limited to angiotensina-converting 
enzyme (ACE) inhibitor, angiotensina receptor blockers II 
(AT1 blocker) and/or diuretics (Table 1). Exclusion criteria 
included: (1) age between 36 and 59 years, (2) use of lipid-
lowering drugs or other agents that could inﬂ  uence the results 
of the tests, (3) cancer or any severe chronic-degenerative 
diseases, (4) impairment, (5) dementia, (6) renal failure, (7) Clinical Interventions in Aging 2008:3(3) 527
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secondary hypertension, (8) diabetes mellitus (DM), and 
(9) triglycerides higher than 400 mg/dL%.
Methodology
The eligible subjects, after being informed about the 
investigation and agreeing to take part in it, were submitted 
to a medical interview, medical examination and laboratory 
tests. A standard questionnaire was applied to collect demo-
graphic data, a history of previous medical conditions, and a 
detailed inquiry on medication currently being used. Finally, 
a complete physical examination was performed, and body 
mass index (BMI) was calculated (kg/m2). A blood sample of 
all participants was collected for assessment of lipid proﬁ  le, 
and all underwent an EKG and carotid ultrasound.
BP measurement was according to the guidelines of 
the Joint National Committee-Seventh Report (JNC VII) 
(2003). Resting BP was measured three times during the 
consultation, with an interval of at least 5 minutes between 
measurements and with the patient in a sitting position, and 
the average of the two last readings that was recorded. Fast-
ing laboratory tests used standard serum enzymatic assays 
in a clinical laboratory whose procedures have validated by 
Brazilian Society of Clinical Pathology. The blood samples 
were collected in the morning until 8:30 AM, after a 10 to 
12-hour fasting, to measure glycosylated hemoglobin, total 
cholesterol (TC), and triglycerides (TG). The high density 
lipoprotein cholesterol (HDL-c) was assessed by lipoprotein 
precipitation, whereas LDL-c was calculated according to 
Friedwald’s formula (Friedwald et al 1972): LDL-c = TC − 
(HDL-c + TG/5). The reference values were CT lower than 
200 mg/dL, LDL-c lower than 130 mg/dL, and HDL-c of 40 
mg/dL or above, for the control groups, as indicated by the III 
Brazilian Consensus of Dyslipidemia (2001), and values of 
CT of 200 mg/dL or above, LDL-c of 130 mg/dL or above, 
and HDL-c lower than 40 mg/dL for groups III and IV. For 
glucose levels, the new criteria of the American Diabetes 
Association (ADA) (2003) for the diagnosis of DM were 
considered. The ultrasound examinations were obtained with 
an echocardiograph model Apogee 800 plus, proper to study 
vessels, with a 32-second scroll system for mode-M and 
Doppler. For the tests, a multi-frequency transducer ranging 
from 5 to 8 MHz was used. The investigation of the arteries 
was guided by the ultrasound rays, which hit the vessel wall 
perpendicularly, forming a typical 2-line image separated 
by an anechoic space, allowing the identiﬁ  cation of anterior 
and posterior wall structures. These lines are limited by the 
blood-intima and media-adventitia interfaces. The distance 
between these two lines is the intima-media thickness of the 
vascular wall (Baldassarre et al 1996; Sidhu and Desai 1996; 
Smilde et al 1997; ASE 2006). All examinations were carried 
out by the same operator (Smilde et al 1997).
IMT measurement was performed in the distal portion of 
the right carotid artery (RCA) and left carotid artery (LCA), 
1 cm away from the bifurcation, on the deepest wall, from 
longitudinal cuts to have a better view of the vessels and 
their walls (ASE 2006), which allowed identiﬁ  cation of 
Table 1   The inclusion criteria
 Age  (Years)  Blood  pressure  Lipids  Drugs
Group I  Between 18 and 35  normal  normal  Without drugs CV action
n = 30       
Male = 19       
Female = 11       
Group II  60 or more years  normal  normal  Without drugs CV action
n = 30       
Male = 10       
Female = 20       
Group III  60 or more years  isolated systolic hypertension  normolypidemia  ACE inhibitor or AT1  
       and/or/or  diuretics
n = 30       
Male = 12       
Female = 18       
Group IV  60 or more years  isolated systolic hypertension  dyslipidemia  ACE inhibitor or AT1  
       and/or/or  diuretics
n = 39       
Male = 15       
Female = 24       
Abbreviations: n, number; CV, cardiovascular;   ACE, angiotensin-converting enzyme;   AT1, angiotensin receptor 1.Clinical Interventions in Aging 2008:3(3) 528
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marked angles and sinuousities. The presence of plaques 
was investigated throughout left and right carotid arteries, 
bulb, and internal (IB) and external (EB) branches. The 
carotid wall with a intima-media thickness of less than 
1 mm, ascertained by echocardiogram performed according 
to the described methodology, was considered normal. IMT 
was considered for values between 1 mm and 1.99 mm. The 
presence of plaque was identiﬁ  ed by a well-deﬁ  ned area with 
IMT 50% bigger, reaching at least 2 mm, when compared 
to surrounding areas that could be clearly viewed (Suurkula 
et al 1994; Millio et al 2006).
Results
Comparison of the investigated variables 
between groups I and II
Table 2 presents the means ± standard deviation of the 
continuous variables investigated in groups I and II. 
Mean SBP readings presented statistically signiﬁ  cant 
differences between the control groups. Mean DBP was 
higher for group II versus group I, which was also statisti-
cally signiﬁ  cant. Lipid assessment was also signiﬁ  cantly 
different in the comparison of the means of all variables 
examined, higher for group II versus group I. IMT-RCA 
assessment showed a higher mean value for group II 
versus group I, a statistically significant difference. 
Mean IMT-LCA value was higher also in group II. Table 
3 presents the categorical variables for groups I and II 
analyzed through the Chi-square test (χ2). Analyzing the 
prevalence of abnormal IMT-RCA values, it was observed 
a statistically significant difference (χ2 = 12.0000, 
p = 0.0005). Abnormal IMT-LCA was found in a statisti-
cally signiﬁ  cant difference (χ2 = 15.0000, p = 0.0001). 
When both carotid arteries were analyzed (left and/or 
right) a statistically signiﬁ  cant difference was observed 
(χ2 = 21.8200, p   0.0001) (Table 3).
Overall features of the groups of elderly
Table 4 presents the means ± standard deviation of the 
continuous variables analyzed of groups II, III and IV, thus 
including all elderly subjects of this investigation. Compari-
son of the means of the variables of normal distribution was 
made through a Variance Analysis test (F). For discrepant 
variances, and for variables with not normal distribution, 
comparison among the groups was made through the Kruskal-
Wallis test (H). Analysis of the means of cholesterol levels 
showed statistically signiﬁ  cant difference (H = 49.6187, 
p   0.0001) when comparing the 3 groups. Comparing the 
groups 2 by 2, the mean of group IV (247.00 ± 41.73 mg/dL) 
was signiﬁ  cantly higher than of group II (186.80 ± 16.91 
mg/dL) and of group III (176.93 ± 20.53 mg/dL); the mean 
of group II, however, was similar to the one of group III. 
Comparing the means of LDL-c, the difference among the 
3 groups is signiﬁ  cant (H = 56.6229, p   0.0001). The mean 
of group IV (167.02 ± 36.00 mg/dL) was signiﬁ  cantly higher 
when compared to the means of group III (101.23 ± 21.08 
mg/dL) and group II (108.54 ± 19.12 mg/dL), but the means 
of these two groups, II and III, are similar. Comparison of the 
HDL-c mean values among the 3 groups showed statistical 
signiﬁ  cance (H = 7.8216, p = 0.02), being the mean of group 
II (54.12 ± 15.18 mg/dL) higher than the mean of groups 
III (49.01 ± 7.84 mg/dL) and IV (45.31 ± 12.21 mg/dL), 
which had similar mean ﬁ  gures. As for triglycerides, the 
mean value of group IV (173.38 ± 78.71 mg/dL) was higher 
than the means of groups III (133.57 ± 45.01 mg/dL) and II 
Table 2 Comparative analysis of controls groups
Variable  Group I  Group II  Statistic test  p
Age 24.70  ± 4.16  71.77 ± 8.65  U = 0.0   0.0001
Weight 64.50  ± 9.14  65.00 ± 11.51  t = 0.18  0.862
Height 1.69  ± 0.09  1.61 ± 0.08  t = 3.80   0.001
BMI 22.63  ± 3.01  25.11 ± 3.72  t = 2.85  0.006
SBP 114.63  ± 7.49  125.17 ± 9.19  t = 4.87   0.001
DBP 71.73  ± 5.49  75.63 ± 6.51  t = 2.51  0.020
Cholesterol 159.80  ± 24.02  187.10 ± 15.72  U = 160.0   0.001
LDL-c 97.00  ± 18.20  108.54 ± 19.12  t = 2.39  0.020
HDL-c 45.90  ± 13.08  54.11 ± 15.18  t = 2.25  0.028
TG 84.43  ± 35.04  123.73 ± 54.30  U = 254.5  0.004
Glucose 87.80  ± 11.42  91.83 ± 13.00  t = 1.28  0.206
IMT-RCA 0.61  ± 0.10  0.95 ± 0.20  U = 32.5  0.001
IMT-LCA 0.55  ± 0.10  0.97 ± 0.22  U = 15.5   0.001
Abbreviations: BMI, body mass index; LDL-c, low density lipoprotein cholesterol; HDL-c, high density lipoprotein; TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic 
blood pressure; IMT-RCA, intima-media thickening right carotid artery; IMT-LCA, intima-media thickening left carotid artery.Clinical Interventions in Aging 2008:3(3) 529
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(123.73 ± 54.27 mg/dL), which did not present a signiﬁ  cant 
difference.
SBP means were similar for groups III and IV, and both 
were signiﬁ  cantly higher than for group II (F = 72.5561, 
p = 0.0001). The mean for group III was 166.63 ± 16.08 
mmHg, and for group IV, 166.80 ± 20.07 mmHg, whereas 
for group II it was 125.17 ± 9.19 mmHg. DBP assessment 
showed higher and similar mean values for groups III (83.30 ± 
4.81 mmHg) and IV (84.08 ± 3.30 mmHg). When compared 
to group II (75.63 ± 6.51 mmHg), there was a signiﬁ  cant 
statistical difference (H = 33.5633, p = 0.0001). In terms of 
pulse pressure, comparison among the 3 groups evidenced a 
statistically signiﬁ  cant difference (p = 0.0001), with III and 
IV presenting means higher than II (49.53 ± 8.61 mmHg), 
but similar one to the other (82.33 ± 16.5 mmHg and 84.72 ± 
18.51 mmHg respectively). Comparison of the IMT-RCA 
among the 3 groups showed statistically signiﬁ  cant difference 
(F = 4.1861, p = 0.0181). The mean of group III was higher 
than of the other groups (1.10 ± 0.24 mm), and the mean of 
group II (0.95 ± 0.20 mm) was similar to the one of group 
IV (1.00 ± 0.18 mm). The analysis of IMT-LCA mean values 
did not reveal statistically signiﬁ  cant difference (F = 1.7432, 
p = 0.1805). The mean of group II was of 0.97 ± 0.22 mm; 
group III, 1.07 ± 0.27; and group IV, 1.05 ± 0.22 mm.
Distribution of the categorical variables 
assessed in the groups of elderly
The categorical variables examined in groups II, III and IV 
are presented in Table 5. In the comparison among groups, 
a statistically signiﬁ  cant difference was observed regarding 
the use of medication among the 3 groups (χ2 = 99.0000, 
p   0.0001). In groups III and IV, all subjects (100%) used 
a medication, whereas in group II, none of them did (0%). 
For the presence of PlaqueR, there was signiﬁ  cant differ-
ence in the comparison among the 3 groups (χ2 = 6.6194, 
p = 0.0365). The presence of PlaqueL was also statistically 
signiﬁ  cant (χ2 = 6.6558, p = 0.0358) among the groups. 
The presence of plaque in the RLCA had also a statistically 
signiﬁ  cant distribution among the 3 groups (χ2 = 10.0839, 
p = 0.0065). When comparing distribution of IMT-RCA 
among the 3 groups, it was seen at a lower prevalence in the 
group of healthy elderly compared to the other groups, with 
the difference being statistically signiﬁ  cant (χ2 = 11.4265, 
p = 0.0033). Regarding the presence of IMT-LCA, there was 
no signiﬁ  cant difference among the 3 groups (χ2 = 5.4892, 
p = 0.0643). Similarly, there was no statistically signiﬁ  cant 
difference in the distribution of IMT-RLCA among the 3 
groups (χ2 = 5.2484, p = 0.0725).
Table 3 Distribution of analyzed continuous variables in control-
groups
Variable  Group I  Group II  Statistic test χ2 p
Gender (M ⁄ F)  19 ⁄ 11  9 ⁄ 21  6.7000  0.0100
Overweight (Y ⁄ N)  6 ⁄ 24  15 ⁄ 15  6.0000  0.1490
IMT-RCA (Y ⁄ N)  0 ⁄ 30  10 ⁄ 20  12.0000  0.0005
IMT-LCA (Y ⁄ N)  0 ⁄ 30  12 ⁄ 18  15.0000  0.0001
IMT-RLCA (Y ⁄ N)  0 ⁄ 30  16 ⁄ 14  21.8200   0.0001
PlaqueR (Y ⁄ N)  0 ⁄ 30  4 ⁄ 26  4.2857  0.0562
PlaqueL (Y ⁄ N)  0 ⁄ 30  4 ⁄ 26  4.2857  0.0600
PlaqueRL (Y⁄ N)  0⁄ 30  5⁄ 25  5.5000  0.0522
Abbreviations: Y, yes; N, no; M, male; F, female; IMT-RCA, intima-media thickening 
right carotid artery; IMT-LCA, intima-media thickening left carotid artery; IMT-RLCA, 
intima media thickening right or left carotid artery; PlaqueR, plaque in right carotid; 
PlaqueL, plaque in left carotid; PlaqueRL, plaque in right or left carotid.
Table 4 Baseline characteristics of studied elderly groups
Variable  Group II  Group III  Group IV  Statistic test  Value de p  Comparison 2 a 2
Age 71.77  ± 8.64  71.20 ± 7.16  70.03 ± 7.15  F = 0.4720  0.6252  ______
Weight 64.96  ± 11.52  64.45 ± 11.01  70.01 ± 12.30  F = 2.3290  0.1032  ______
Height 1.61  ± 0.08  1.61 ± 0.10  1.61 ± 0.08  F = 0.0188  0.9814  ______
BMI 25.11  ± 3.72  25.09 ± 3.34  27.17 ± 4.90  F = 2.9600  0.0566  ______
Cholesterol 186.80  ±16.91 176.93  ± 20.53  247.00 ± 41.73  H = 49.6187   0.0001 4    3 = 2
LDL-c 108.54  ± 19.12  101.23 ± 21.08  167.02 ± 36.00  H = 56.6229   0.0001 4    3 = 2
HDL-c 54.12  ± 15.18  49.01 ± 7.84  45.31 ± 12.21  H = 7.8216  0.0200  2   4 = 3
TG 123.73  ± 54.27  133.57 ± 45.01  173.38 ± 78.71  H = 9.4884  0.0087  4   3 = 2
Glucose 91.83  ± 12.96  90.00 ± 11.50  96.62 ± 13.90  F = 2.2825  0.1078  ______
SBP 125.17  ± 9.19  166.63 ± 16.08  166.80 ± 20.07  F = 72.5561  0.0001  4 = 3   2
DBP 75.63  ± 6.51  83.30 ± 4.81  84.08 ± 3.30  H = 33.5633  0.0001  4 = 3   2
PULSEP 49.53  ± 8.61  82.33 ± 16.5  84.72 ± 18.51  H = 50.9636  0.0001  4 = 3   2
IMT-RCC 0.95  ± 0.20  1.10 ± 0.24  1.00 ± 0.18  F = 4.1861  0.0181  3   2 = 4
IMT-LCCA 0.97  ± 0.22  1.07 ± 0.27  1.05 ± 0.22  F = 1.7432  0.1805  ______
Abbreviations: BMI, body mass index; LDL-c, low density lipoprotein cholesterol; HDL-c, high density lipoprotein; TG, triglycerides; SBP, systolic blood pressure; DBP, diastolic blood 
pressure; PULSEP, pulse pressure; IMT-RCC, intima-media thickening common right common carotid; IMT-LCCA, intima-media thickening common left common carotid.Clinical Interventions in Aging 2008:3(3) 530
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Evaluation of categorical variables 
regarding ISH
The assessment of the frequency distribution of the cat-
egorical variables examined in relation to ISH is shown in 
Table 6.
In regards to the presence of dyslipidemia, there was 
signiﬁ  cant difference between the two groups (χ2 = 27.9783, 
p   0.00001). The distribution of IMT-RCA between 
the 2 groups was statistically signiﬁ  cant (χ2 = 8.6087, 
p = 0.0034). Comparison of IMT-LCA distribution between 
the 2 groups showed a statistically signiﬁ  cant difference 
(χ2 = 5.4435, p = 0.0196). In regards to PlaqueR and to 
PlaqueL distribution, there was a statistically signiﬁ  cant 
difference between the 2 groups (χ2 = 6.4696, p = 0.0110 
and χ2 = 4.7426, p = 0.0294, respectively). Comparing 
the distribution of PlaqueRL between the 2 groups, there 
was a statistically signiﬁ  cant difference (χ2 = 10.0724, 
p = 0.0040).
Evaluation of the categorical variables 
regarding dyslipidemia
Distribution of the categorical variables in regards to 
dyslipidemia is presented in Table 7. The distribution of ISH 
between the dyslipidemia-free and dyslipidemia groups had a 
statistically signiﬁ  cant difference (χ2 = 27.9783, p   0.0001). 
When the use of medication was compared between the 
dyslipidemia and the dyslipidemia-free groups, a statisti-
cally signiﬁ  cant difference was observed (χ2 = 27.9783, 
p   0.0001). The presence of IMT and Plaque in the 2 groups 
had no statistically signiﬁ  cant difference of distribution.
Odds ratio for the presence of IMT in ISH
Odds ratio was calculated to assess the likelihood of IMT 
when ISH was present. Table 8 presents the odds ratio for 
IMT of the carotid arteries in ISH cases. The odds ratio for 
the presence of IMT-RCA in ISH cases was of 1.9167. The 
relative risk for IMT-RCA was of 3.75 times considering 
the absence of ISH/presence of ISH ratio (χ2 = 8.6671, 
p = 0.0032). For the presence of IMT-LCA in ISH cases, the 
odds ratio was 1.7250. The relative risk for IMT-LCA was 
2.81 times, considering the absence of ISH/presence of ISH 
ratio (χ2 = 5.4204, p = 0.0199). The odds ratio for IMT-RLCA 
in ISH cases was of 1.8941. The relative risk for IMT-RLCA 
was 2.67 times, considering the absence of ISH/presence of 
ISH ratio (χ2 = 4.5700, p = 0.0325).
Table 9 presents the odds ratio in ISH cases for occurrence 
of plaques in the carotid arteries. Odds ratio was used to cal-
culate the likelihood of occurring plaques in carotid arteries 
of ISH patients. The odds ratio for the presence of PlaqueR in 
ISH patients was 1.4238. The relative risk for occurrence of 
PlaqueR was 4.18 times, considering the absence of ISH/pres-
ence of ISH ratio (χ2 = 7.1458, p = 0.0075). In regards to ISH, 
the odds ratio for occurence of PlaqueL was 1.3289. The rela-
tive risk for PlaqueL was 3.47 times, considering the absence 
Table 5 Distribution of categorical variables in groups II, III e IV
Variable  Group II  Group III  Group IV  Statistic test χ2  p
Gender (M⁄ F)  9 ⁄ 21  12 ⁄ 18  15⁄ 24  0.7706  0.6803
Overweight (Y⁄ N)  15 ⁄ 15  19 ⁄ 11  25 ⁄ 14  1.6502  0.4382
Drugs (Y⁄ N)  0 ⁄ 30  30 ⁄ 0  39 ⁄ 0  99.0000   0.0001
PlaqueR (Y⁄ N)  4 ⁄ 26  11 ⁄ 19  16 ⁄ 23  6.6194  0.0365
PlaqueL (Y⁄ N)  4 ⁄ 26  13 ⁄ 17  11 ⁄ 28  6.6558  0.0358
PlaqueRL (Y⁄ N)  5 ⁄ 25  15 ⁄ 15  20 ⁄ 19  10.0839  0.0065
IMT-RCA (Y⁄ N)  10 ⁄ 20  23 ⁄ 7  22⁄ 17  11.4265  0.0033
IMT-LCA (Y⁄ N)  12 ⁄ 18  20⁄ 10  25 ⁄ 14  5.4892  0.0643
IMT-RLCA (Y⁄ N)  16 ⁄ 14  24 ⁄ 6  28 ⁄ 11  5.2484  0.0725
Abbreviations: M, male; F, female; Y, yes; N, no; PlaqueR, right plaque; PlaqueL, left plaque; PlaqueRL, plaque in right and or left carotid; IMT-RCA, intima-media thickening right   
carotid artery; IMT-LCA, intima-media thickening left carotid artery; IMT-RLCA, intima-media thickening right and/or left carotid artery.
Table 6 Evaluation of studied continuous categoric variables 
related to ISH
Variable Without  With  Statistic  p
 ISH  ISH  test  χ2 
Gender (M⁄ F)  9 ⁄ 21  27 ⁄ 42  0.7533  0.3855
Dyslip (S⁄ N)  0 ⁄ 30  39 ⁄ 30  27.9783  0.00001
Overweight (Y⁄ N)  15 ⁄ 15  44 ⁄ 25  1.6461  0.1995
IMT-RCA (Y ⁄ N)  10 ⁄ 20  45 ⁄ 24  8.6087  0.0034
IMT-LCA (Y ⁄ N)  12 ⁄18 45  ⁄ 24  5.4435  0.0196
IMT-RLCA (Y ⁄ N)  16 ⁄14 52  ⁄ 17  4.7176  0.0299
PlaqueR (Y ⁄ N)  4 ⁄ 26  27 ⁄ 42  6.4696  0.0110
PlaqueL (Y ⁄ N)  4 ⁄ 26  24 ⁄ 45  4.7426  0.0294
PlaqueRL (Y⁄ N)  5 ⁄ 25  35 ⁄ 34  10.0724  0.0040
Abbreviations: ISH, isolated systolic hypertension; M, male; F, female; Y, yes; N, no; 
Dyslip, dyslipidemia; IMT-RCA, intima-media thickening right carotid artery; IMT-LCA, 
intima-media thickening left carotid artery; IMT-RLCA, intima-media thickening right 
and/or left carotid artery; PlaqueR, right plaque; PlaqueL, left plaque; PlaqueRL, plaque 
in right and or left carotid.Clinical Interventions in Aging 2008:3(3) 531
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of ISH/presence of ISH ratio (χ2 = 5.2088, p = 0.0225). The 
odds ratio for PlaqueRL in ISH patients was 1.6912. The rela-
tive risk for PlaqueRL was 5.15 times, considering the absence 
of ISH/presence of ISH ratio (χ2 = 10.9001, p = 0.001).
Discussion
In the ﬁ  rst stage of this investigation, groups I and II, which 
included, respectively, younger and healthy elderly subjects 
(Table 2) were compared. The purpose was to identify the 
main differences between the 2 groups in order to establish 
the normal parameters for the healthy elders.
Many authors (La Rosa 1996; Sega et al 1997) have found 
higher mean SBP and DBP values in healthy elders when 
compared with healthy younger subjects. Sega and colleagues 
(1997) randomized a sample of 800 subjects, stratifying by 
gender and age (65 to 74 years). BP was measured at 3 differ-
ent points, and the mean values were compared to the mean 
values previously established in a younger population. After 
statistical calculations, higher mean BP values were found for 
the group of elderly subjects. In this study, similar results were 
found, with mean values signiﬁ  cantly higher for both SBP 
(p   0.001) and DBP (p = 0.020) for group II versus group I.
When the mean values for lipids were analyzed in the 2 
groups, total cholesterol, LDL-c and TG were signiﬁ  cantly 
higher in group II versus group I, and these are unanimously 
accepted risk factors for CVD. However, also the mean 
HDL-c values were higher for the group of elderly, and this 
was statistically signiﬁ  cant (p = 0.028) versus the group 
of younger people, and this is a protective factor for the 
development of CVD. These results were similar to those 
of other studies, such as La Rosa’s (1996), in which there 
was observed an increase in the levels of total cholesterol, 
LDL-c, TG, and HDL-c with age.
In regards to the IMT for both RLCA, comparison of the 
means between the 2 groups was statistically signiﬁ  cant at 
p = 0.001 and p   0.001, respectively. In our investigation, 
it was observed that aging contributes to IMT of the carotid 
arteries. Garcia and colleagues (1996) have associated both 
IMT and presence of plaque, to aging. Hughes and associ-
ates (1995) observed and association between IMT and 
aging, even in normotensive subjects. However, Fabris and 
colleagues (1994), in spite of having related IMT to aging, 
observed that this did not occur in very old subjects, and 
raised the possibility of RF, except for high BP, playing 
a less important role after the age of 75. Comparison 
between groups I and II has, therefore, shown an associa-
tion between IMT and aging. A number of studies (Suurkula 
et al 1994, 1996; Bonithon-Kopp et al 1996; O’Leary et al 
1996; Howard et al 1997; Wilt et al 1997; Millio et al 2006; 
Wang et al 2006;) have been carried out with the purpose of 
investigating IMT and/or the presence of plaques in connec-
tion with risk factors and CVDs. An increase of the IMT or 
a detection of protuberance in the vascular lumen have both 
been reported as ultrasound markers of atherosclerosis. The 
development of high-resolution ultrasound imaging, such as 
the echo-Doppler, has allowed the recording of echoes of the 
arterial wall, such as the carotid arteries (ASE 2006; Asraﬁ  an 
et al 2007). The reliability of the carotid arteries IMT ultra-
sound images has been extensively examined (Joakimsem 
1997; Sidhu and Desai 1997; Smilde et al 1997; ASE 2006; 
Asraﬁ  an et al 2007). Sidhu and Desai (1997) demonstrated 
the reliability of the method by measuring the distal wall of 
common artery, always on a longitudinal plan 1 cm away 
from the bulb. Comparison among the 3 groups allowed the 
authors to conclude that theirs was an accurate and reliable 
method to assess IMT of the carotid arteries. Smilde and col-
leagues (1997) examined carotid and femoral arteries using a 
similar methodology, and concluded that the measurement of 
IMT is reliable, even if IMT is present. The IMT mean values 
in their investigation were similar to those of population 
Table 7 Evaluation of continuous categoric variables studied related to dyslipidemia
Variable  Without dyslipidemia  With dyslipidemia  Statistic test χ2  p
Gender (M⁄ F)  21 ⁄ 39  15 ⁄ 24  0.1224  0.7265
ISH (Y⁄ N)  30 ⁄ 30  39 ⁄ 0  27.9783   0.0001
Drugs (Y⁄ N)  30 ⁄ 30  39 ⁄ 0  27.9783   0.0001
MT-RCA (Y ⁄ N)  33 ⁄ 27  22 ⁄ 17  0.0190  0.8903
IMT-LCA (Y ⁄ N)  32 ⁄ 28  25 ⁄ 14  1.1223  0.2894
IMT-RLCA (Y⁄ N)  20 ⁄ 40  11 ⁄ 28  0.2890  0.5909
PlaqueR (Y ⁄ N)  15 ⁄ 45  16 ⁄ 23  2.8223  0.0930
PlaqueL (Y ⁄ N)  17 ⁄ 43  11 ⁄ 28  0.0020  0.9890
PlaqueRL (Y⁄ N)  20 ⁄ 40  20 ⁄ 19  3.1623  0.0753
Abbreviations: M, male; F, female; Y, yes; N, no; ISH, isolated systolic hypertension; IMT-RCA, intima-media thickening right carotid artery; IMT-LCA, intima-media thickening left   
carotid artery; IMT-RLCA, intima-media thickening right and/or left carotid artery; PlaqueR, right plaque; PlaqueL, left plaque; PlaqueRL, plaque in right and or left carotid.Clinical Interventions in Aging 2008:3(3) 532
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studies, such as the Atherosclerosis Risk in Communities 
(ARIC) (Howard et al 1997), the Vascular Aging Study 
(EVA) (Bonithon-Kopp et al 1996), and the Risk Intervention 
Study Group (RIS) (Suurkula et al 1994), among others. The 
means found in our study match these values.
The setting of a group of healthy elders (group II) has 
allowed comparison between this control group with group 
III, of ISH elders, and group IV, of elders with ISH and 
dyslipidemia, in order to assess the importance of aging, of 
anthropometric indices, of ISH and of dyslipidemia in IMT 
(Table 4).
As for the presence of IMT-RCA (Table 5), there was 
statistically signiﬁ  cant difference among groups II, III and 
IV (p = 0.0033), with higher values for groups III and IV. 
However, when IMT-LCA and IMT-RLCA were analyzed, 
in spite of higher values for groups III and IV, they did not 
reach statistical signiﬁ  cance, with p = 0.0643 and p = 0.0725, 
respectively.
The possible antiatherosclerotic action of antihyper-
tensive agents, regardless of their hypotensive effects, has 
been focused by a number of works. Measurement of carotid 
arteries IMT was used as a parameter to assess the process of 
atherosclerosis (Bonithon-Kopp et al 1996; Wang et al 2006; 
Girerd et al 1998; Zanchetti 1996), which leads to a initial 
conclusion that ACEIs and calcium channels antagonists 
would be effective in reducing IMT. Based on these results, 
this investigation standardized the antihypertensive agents 
used by the patients, over concern on their inﬂ  uence over 
IMT. For the same reason, patients using lipid-lowering 
drugs were excluded (Salonem et al 1995; Baldassare et al 
1996; Hodis et al 1996; Spacil et al 1997).
Presence of plaque was analyzed in the 3 groups (Table 5), 
and signiﬁ  cant difference was found, with lower prevalence 
in group II for PlaqueR (p = 0.0365), PlaqueL (p = 0.0358) 
and PlaqueRL (p = 0.0065).
The results from the comparison of groups II, III and 
IV (Table 5) lead to the conclusion that, in groups III and 
IV, there was a positive association between ISH and/or 
dyslipidemia and IMT-RCA and presence of PlaqueR, 
PlaqueL and PlaqueRL. However, it was through the com-
parison between subjects without and with ISH, and those 
without and with dyslipidemia, that one could establish the 
association between ISH and dyslipidemia in regards to IMT 
and presence of plaque.
A number of works (Van Merode et al 1993; Suurkula 
et al 1994; Wilson et al 1994; Hughes et al 1995; Bonithon-
Kopp et al 1996; Panza 1997) in hypertensive subjects, 
using carotid ultrasound imaging to measure the IMT, have 
found a positive relationship between high BP, IMT and 
presence of plaques in the carotid arteries. O’Leary and 
colleagues (1996) found a strong association between ISH 
and IMT in the population they investigated. In our study, 
the results from the comparison between elderly with ISH 
and normotensive elderly subjects were in accordance with 
the reviewed literature (Table 6). Assessment of the IMT 
revealed higher values for the hypertensive group, of statisti-
cal signiﬁ  cance for all, IMT-RCA (p = 0.0034), IMT-LCA 
(p = 0.0196) and IMT-RLCA (p = 0.0299). The relative risk 
for the presence of IMT, considering the absence of ISH/
presence of ISH ratio, was of 3.75 for IMT-RCA; 2.81 for 
IMT-LCA; and 2.67 for IMT-RLCA (Table 8). Similarly, 
comparison between elders with and without in regards to 
the presence of plaques also showed signiﬁ  cantly higher 
values for the hypertensive group for PlaqueR (p = 0.0110), 
PlaqueL (p = 0.0294) and PlaqueRL (p = 0.0040) (Table 6). 
Considering the absence of ISH/presence of ISH ratio, the 
relative risk was 4.18 for PlaqueR, 3.47 for PlaqueL, and 
5.15 for PlaqueRE. These results evidenced the positive 
association between ISH and presence of IMT and presence 
of plaques in carotid arteries (Table 9).
In regards to dyslipidemia, observation studies in elderly 
populations have showed contradictory results. O'Leary 
and colleagues (1996) investigated a population of 5117 
subjects with 65 years or older, and found a positive relation 
between high levels of LDL-c and IMT, while high levels 
of HDL-c presented a negative relationship. Bonithon-Kopp 
and associates (1996) observed a positive relationship 
Table 8 ISH and odds ratio for IMT
  Odds  CI 95%  Relative risk   χ2  p
     HSI no/HSI yes
IMT-RCA 1.9167  1.2715–2.8892  3.75  8.6671  0.0032
IMT-LCA 1.7250  1.1159–2.6667  2.81  5.4204  0.0199
IMT-RLCA 1.8941 1.0790–3.3250 2.67  4.5700 0.0325
Abbreviations: Odds, odds ratio; CI, conﬁ  dence interval; ISH, isolated systolic 
hypertension; χ2, chi-square; p, standard deviation; IMT-RCA, intima-media thickening 
right carotid artery; IMT-LCA, intima-media thickening left carotid artery; IMT-RLCA, 
intima-media thickening right and/or left carotid artery.
Table 9 ISH and odds ratio for plaque
  Odds  IC 95%  Relative risk   χ2  p
     HSI no/HSI yes
PlacaR 1.4238  1.1250–1.8020  4.18 7.1458  0.0075
PlacaL 1.3289  1.0641–1.6596  3.47 5.2088  0.0225
PlacaRL 1.6912 1.2680–2.2555  5.15  10.9001  0.001
Abbreviations: ISH, isolated systolic hypertension; Odds, odds ratio; CI, conﬁ  dence 
interval; ISH, isolated systolic hypertension; χ2, chi-square; p, standard deviation; PlaqueR, 
right plaque; PlaqueL, left plaque; PlaqueRL, plaque in right and or left carotid.Clinical Interventions in Aging 2008:3(3) 533
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between cholesterol levels and presence of plaques in the 
carotid arteries; however, no relationship was found for 
IMT. Surkula and colleagues (1994) in the Multiple Risk 
Intervention in High-Risk Hypertensive Patients study did 
not ﬁ  nd a positive relationship between high cholesterol 
levels and IMT in an elderly population. In our work, we 
did not ﬁ  nd a positive relationship between dyslipidemia 
and IMT, and it was not a risk variable for the presence 
of plaque. PlaqueRL did have a marginal statistic value 
(p = 0.0753) (Table 7), but these results are probably not 
statistically relevant due to the small number of the sample 
subjects (n = 39).
Conclusion
In this investigation, it was evidenced that the measurement 
of the intima-media thickness through ultrasound imaging, 
a noninvasive, low-cost, easy-to-perform method, was valid 
to assess IMT of carotid arteries in elderly subjects. The 
results showed aging to be an independent factor positively 
related to IMT. It was also possible to demonstrate that ISH 
was a RF of IMT of the RCA (p = 0.0034), IMT of the LCA 
(p = 0.0196), and IMT of the RCA and/or LCA (p = 0.0299), 
as well as a RF for the development of plaque in RCA 
(p = 0.110), plaque in the LCA (p = 0.294), and plaque in 
RCA and/or LCA (p = 0.040). However, to ascertain the 
role of dyslipidemia in the development of IMT and of 
plaques in carotid arteries of elderly subjects, we believe it 
is necessary a longitudinal follow-up of the studied popu-
lation, to establish, once and for all, as it already happens 
with ISH, the importance of management and treatment of 
dyslipidemia in elders.
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